- Home
- SRPT vs PRCT Comparison
SRPT vs PRCT Comparison
Compare SRPT & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | PRCT |
|---|---|---|
| Founded | 1980 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.0B |
| IPO Year | 1997 | 2021 |
Fundamental Metrics
Financial Performance| Metric | SRPT | PRCT |
|---|---|---|
| Price | $23.85 | $32.89 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 29 | 9 |
| Target Price | $26.23 | ★ $51.13 |
| AVG Volume (30 Days) | ★ 2.8M | 1.1M |
| Earning Date | 02-25-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,413,715,000.00 | $299,907,000.00 |
| Revenue This Year | $13.72 | $48.30 |
| Revenue Next Year | N/A | $29.44 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 47.15 | ★ 50.07 |
| 52 Week Low | $10.42 | $27.80 |
| 52 Week High | $128.75 | $87.45 |
Technical Indicators
Market Signals| Indicator | SRPT | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 64.06 | 48.68 |
| Support Level | $20.86 | $30.60 |
| Resistance Level | $24.12 | $35.20 |
| Average True Range (ATR) | 0.95 | 1.52 |
| MACD | 0.16 | 0.06 |
| Stochastic Oscillator | 92.22 | 46.04 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.